Trial Profile
Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2020
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- Acronyms PEARL
- 02 May 2020 Status changed from suspended to completed.
- 12 Jul 2019 Status changed from not yet recruiting to suspended.
- 20 Aug 2015 New trial record